June 26, 2025

Today is National Report Trade Agreement Act (TAA) Fraud Day, spreading awareness of fraud against the government and informing the public how to earn a reward for reporting it. The day was originated by Joel Hesch, a whistleblower attorney who worked for over 15 years in the Department of Justice.

So, if you have any potential fraud claims, the best way to seize this recognized day is to contact us with inquiries or questions you might have about blowing the whistle.

In this week's edition of Whistleblower Insider...

🎉Congrats to Danitza Nicolle Ceccarelli, the Second-Place Winner of our Fourth Law School Scholarship Essay Contest on the importance of whistleblowers. We've enclosed her winning essay.

🗣️In honor of Pride Month, we are highlighting some of the many great LGBTQ+ artists, politicians, activists, writers, allies, and others who have used their platforms to facilitate change and spark dialogues.

💸 We reported on a $3.6M settlement involving False Claims Act allegations about a company's marketing of a fentanyl drug.

📰 Plus, more updates and whistleblower-related news.

Honoring Pride Month with Our Spotlight on LGBTQ+ Whistleblowers

Explore our round-up of LGBTQ+ activists and cultural truth tellers who possess character traits often associated with whistleblowers: courage, willingness to take a stand in the face of injustice, integrity, and perseverance. These are individuals who have used their platform to address inequalities, challenge societal norms, and confront systems of repression through art, visibility, and advocacy.

Read the full story here.

 Second Place Winner of Constantine Cannon’s Whistleblower Essay Contest: Danitza Nicolle Ceccarelli

Danitza is a passionate advocate for equity and systemic change, grounded in a lifelong commitment to social justice. In her essay, read what she learned from her mother’s brave decision to blow the whistle at a hospital, and how these events impacted her worldview.

Read the full story here.

 Assertio to Pay $3.6M in False Claims Act Settlement over Fentanyl Marketing Practices

Assertio agreed to pay $3.6 million to resolve False Claims Act allegations stemming from its marketing of Lazanda, its transmucosal immediate-release fentanyl (TIRF) drug - a nasal spray solely approved by the FDA for patients with breakthrough cancer pain who are receiving and are tolerant to opioid therapy. This case was initiated by whistleblowers.

Read the full story here.

In Case You Missed It:

• Constantine Cannon LLP and Partner Ankur Kapoor Recognized In Chambers USA Guide 2025, Antitrust: Mainly Plaintiff Rankings
  
  
• ‘Speak Now’: How Taylor Swift is a Whistleblower and Stays ‘Fearless’ in Every Era
  
  
• Coin Con: Two Companies and Co-Conspirators Pay $25M+ in Crypto Scam
  
  
• Third Place Winner of Constantine Cannon’s Whistleblower Essay Contest: Taylor Colvin